Tatiana Zhelninova - Bosch

専門分野: Cardiologist
33年の経験
話します:
English, Russian
オンラインコンサルテーション：利用可能
勤務先: タイ, プーケット, The Demarest Clinic
タチアナ・ジェルニノヴァ＝ボッシュ医師（MD, PhD）は、心臓病学、家庭医学、再生医療において25年以上の経験を持つ、世界的に著名な医師です。ハダサー・メディカル・センターの国際部門を含む名門クリニックを率い、患者のアクセス拡大や臨床試験の先駆的な取り組みを行ってきました。幹細胞療法のリーダーとして、世界のエリート機関で研鑽を積み、アラブ・ヘルスなどの国際フォーラムでも講演を行っています。ロシア保健省から名誉証明書を授与された彼女の、思いやりと専門知識に基づいたケアは、患者が回復の旅路において自信とサポートを感じられることを約束します。
タチアナ・ジェルニノヴァ＝ボッシュ医師は、プーケットのデマレスト・クリニックに勤務する心臓専門医であり、再生医療のスペシャリストです。幹細胞療法と臨床試験管理における第一人者として知られています。ジェルニノヴァ＝ボッシュ医師は以前、ハダサー・メディカル・モスクワの主任医師および医療ディレクターを務めていました。動脈硬化、心不全、肺高血圧症などの複雑な疾患を治療しています。
- 心疾患およびアンチエイジング治療にドナーおよび自己幹細胞を使用。
- ロシア保健省より名誉証明書を授与。
- 中東ハダサー大学病院ヘルス・プラスの元ゼネラルマネージャー。
- タイで初めて同種幹細胞療法の認可を受けたクリニックに勤務。

Tatiana Zhelninova - Boschとのオンラインコンサルテーション

便利で簡単

100%安全で機密

お問い合わせください

医師のサービス

調子はいかがですか？

1 の 3

この医師の情報は完全で明確です

強く反対

強く賛成

資格

Tatiana Zhelninova-Bosch is a cardiologist and regenerative medicine specialist. She is the Senior Medical Director at The Demarest Clinic in Thailand. The doctor uses stem cell therapy and longevity health protocols. She also serves as a researcher in endovascular technologies.

Specialization & Approach

The doctor treats cardiovascular conditions using both traditional and regenerative methods. She applies stem cell therapy to address heart disease and heart failure. Her approach integrates longevity health techniques like ozone and intravenous vitamin C therapy. These therapies aim to improve cellular function and reduce systemic inflammation.

Dr. Zhelninova-Bosch treats these conditions:

Atherosclerosis and coronary artery disease
Arrhythmia and atrial fibrillation
Hypertension and pulmonary hypertension
Dilated cardiomyopathy – a condition where the heart muscle becomes thin and weakened

She performs specific regenerative procedures, including:

Stem cell rejuvenation therapy for anti-aging
Rejuvenation using donor or autologous stem cells
Treatment for chronic pain following hernia surgery

Professional Leadership

Dr. Zhelninova-Bosch has held multiple executive roles in international healthcare institutions. She is the CEO of Imperium Bio@Capital in Dubai. Additionally, she leads the R&D company "Innovation Endovascular Technologies" at Skolkovo. She focuses on healthcare policy and project implementation within these roles.

Her previous leadership experience includes:

2024–Present – Senior Medical Director at American Clinic, Demarest, Thailand
2021–Present – CEO at Imperium Bio@Capital, Dubai, UAE
2020–Present – General Director, R&D Company “Innovation Endovascular Technologies,” Skolkovo
2020–2021 – General Manager at IMA Hadassah University Hospital Health Plus, Middle East
2019–2020 – Chief Physician and Medical Director at Hadassah Medical Moscow, Skolkovo

In her role at Imperium Bio@Capital, she focuses on management and client acquisition. She also gained experience in strategic thinking during her tenure at Hadassah University Hospital Health Plus.

Achievements & Recognition

The doctor received a Certificate of Honor from the Ministry of Health of Russia. She has presented her research at global medical forums such as Arab Health. Furthermore, she helped expand patient access and clinical trials at Hadassah Medical Center. Her work includes significant contributions to healthcare policy and project implementation.

Education & Training

Dr. Zhelninova-Bosch earned her MD and PhD degrees. She started practicing in 1993. The doctor completed clinical training at medical institutions worldwide. Her background includes research in endovascular technologies – which are minimally invasive procedures performed inside blood vessels.